Qing Li

Synthesis of galactosylated chitosan/5-fluorouracil nanoparticles and its characteristics, in vitro and in vivo release studies.

B. Zha, M. Cheng, Jingbo Wu, 2012, Journal of biomedical materials research. Part B, Applied biomaterials.

5-Fluorouracil Nanoparticles Inhibit Hepatocellular Carcinoma via Activation of the p53 Pathway in the Orthotopic Transplant Mouse Model

Tao Wan, B. Zha, M. Cheng, 2012, PloS one.

Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.

Tao Wan, B. Zha, M. Cheng, 2012, World journal of gastroenterology.

Preliminary pharmacology of galactosylated chitosan/5-fluorouracil nanoparticles and its inhibition of hepatocellular carcinoma in mice

Tao Wan, B. Zha, M. Cheng, 2012, Cancer biology & therapy.

Anti-cancer efficacy of biotinylated chitosan nanoparticles in liver cancer

De-jian Dai, M. Cheng, Weiping Zhu, 2017, Oncotarget.

Synthesis and efficient hepatocyte targeting of galactosylated chitosan as a gene carrier in vitro and in vivo.

Tao Wan, B. Zha, M. Cheng, 2011, Journal of biomedical materials research. Part B, Applied biomaterials.